Breast Cancer Online Courses

The Southern Medical Association has 4 new breast cancer CME courses available online, just in time for Breast Cancer Awareness Month.

Breast cancer remains the second most common cancer in women, after lung cancer. By the end of 2017, the American Cancer Society estimates that in the United States, 63,410 women will be diagnosed as having a noninvasive carcinoma in situ breast cancer, 252,710 women will receive a diagnosis of an invasive breast cancer, and 40,610 will die of breast cancer. The overall chance of a women dying of breast cancer is 1 in 37.

SMA Online CME Courses make it easy to obtain AMA PRA Category 1 Credits™.

Courses are available to anyone and are free to Silver or Gold SMA members.

Prices vary based on number of credit hours. Get started now!

Breast Cancer Course Listing

Identification and Management of Tumor Protein p53 Gene Carriers Detected Through Multigene Panel Testing
Price: $10 | Credits: 1

Technological advances made possible through next-generation sequencing-based tests have led to a broad approach to testing for multiple genes simultaneously (called multigene panel testing), including those for which the patient does not meet clinical testing criteria.

Early Postoperative Complications After Oncoplastic Reduction
Price: $10 | Credits: 1

Breast-conserving surgery with adjuvant radiation therapy (BCT) has been established as safe oncologically. Oncoplastic breast surgery uses both oncologic and plastic surgery techniques for breast conservation to improve cosmetic outcomes. In this study, the risk factors associated with complications after oncoplastic breast reduction is evaluated.

Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions
Price: $10 | Credits: 1

Ductal carcinoma in situ (DCIS) is a noninvasive form of breast cancer with an unpredictable risk of either progression to invasive disease or recurrence. The typical treatment of DCIS occurs at the time of diagnosis, which results in the overtreatment of certain patients with a low propensity for disease progression or recurrence.

Hematologic Malignancies Discovered on Investigation of Breast Abnormalities
Price: $10 | Credits: 1

Hematological malignancies of the breast share a presentation similar to primary breast carcinomas but differ substantially in therapeutic approach and clinical outcomes. In this study, the frequency of hematological malignancies, their relative primary and secondary occurrences, and further characterization of the distinct histopathologies of these malignancies with a special focus on lymphomas are investigated.

Leave a Reply

SMA Menu